ArticlePharmacogenetics and genomics2016

A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration.

Laura Lorés-Motta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.